[Federal Register Volume 86, Number 42 (Friday, March 5, 2021)]
[Rules and Regulations]
[Pages 12829-12833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04251]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2017-0653; FRL-10019-99]
Picarbutrazox; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
picarbutrazox in or on multiple commodities which are identified and
discussed later in this document. Nippon Soda Co., Ltd c/o Nisso
America, Inc. requested these tolerances under the Federal Food, Drug,
and Cosmetic Act (FFDCA).
DATES: This regulation is effective March 5, 2021. Objections and
requests for hearings must be received on or before May 4, 2021, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2017-0653, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Marietta Echeverria, Registration
Division (7505P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (703) 305-7090; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Publishing Office's e-CFR site at http://www.ecfr.gov/cgi-bin/
[[Page 12830]]
text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2017-0653 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
May 4, 2021. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2017-0653, by one of
the following methods:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of March 6, 2018 (83 FR 9471) (FRL-9973-
27), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
7F8623) by Nippon Soda Co., Ltd c/o Nisso America, Inc., 88 Pine
Street, 14th Floor, New York, NY 10005. The petition requested that 40
CFR part 180 be amended by establishing tolerances for residues of the
fungicide picarbutrazox, 1,1-Dimethylethyl N-(6-((((Z)-((1-methyl-1H-
tetrazol-5-yl) phenylmethylene) amino)oxy)methyl)-2-
pyridinyl)carbamate, in or on corn, forage at 0.01 parts per million
(ppm); corn, grain at 0.01 ppm; corn, stover at 0.01 ppm; corn, sweet,
forage at 0.01 ppm; corn, sweet, kernel plus cob with husks removed at
0.01 ppm; corn, sweet, stover at 0.01 ppm; crop group 9, cucurbit
vegetables at 0.20 ppm, crop subgroup 4-16A, leafy greens at 10 ppm;
popcorn, grain at 0.01 ppm; soybean, forage at 0.01 ppm; soybean, hay
at 0.01 ppm and soybean, seed at 0.01 ppm. That document referenced a
summary of the petition prepared by Nippon Soda Co., Ltd c/o Nisso
America, the registrant, which is available in the docket, http://www.regulations.gov. Nine comments were received on the notice of
filing. However, they were not germane to this submission.
Based upon review of the data supporting the petition, EPA is
establishing, in accordance with section 408(d)(4)(a)(i), tolerances
that vary in some respects from what the petitioner requested. Also,
EPA is not establishing tolerances for Crop Group 9, Cucurbit
Vegetables and Crop Subgroup 4-16A, Leafy Greens, as the petitioner
withdrew the request for those tolerances after submitting the
petition. The Agency's underlying rationale for those variations are
explained in Unit IV.C.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for picarbutrazox including
exposure resulting from the tolerances established by this action.
EPA's assessment of exposures and risks associated with picarbutrazox
follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The primary target organs for picarbutrazox are the liver and the
thyroid gland across species and durations (except acute). The rat was
the most sensitive species, followed by the mouse and the dog. Both the
liver and the thyroid showed increases in organ weights and
histopathological changes. In the liver, changes included hepatocyte
hypertrophy, periportal vacuolation, cytoplasmic inclusions, and portal
inflammatory cell infiltration. In the thyroid, there were increased
incidences of thyroid hypertrophy which corresponded with increased
thyroid weights in both parental animals and neonates. Disruption of
thyroid hormones was also observed across the guideline studies, for
the short-term and long-term durations in rats (alterations in
triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone
(TSH)). Thyroid follicular tumors were observed in rats following 2
years of oral exposure. No treatment-related effects were observed in
mice following 78 weeks of exposure. There is no evidence of
genotoxicity or mutagenicity in the picarbutrazox hazard database.
There is no evidence of increased prenatal susceptibility in rats
or rabbits or postnatal susceptibility in rats. There were no adverse
fetal or maternal effects in the available developmental toxicity
studies in rats or rabbits. Both studies tested up to the limit dose.
In the multi-generation reproductive study, adverse thyroid effects
were observed in the parental animals and occurred at doses lower than
offspring effects. There were no adverse reproductive effects up to the
highest dose tested (46/63 mg/kg/day).
[[Page 12831]]
Subchronic studies in rats were performed for the numerous plant
metabolites generated from parent picarbutrazox. All were less toxic
than the parent molecule. No signs of neurotoxicity were observed in
the acute neurotoxicity study up to the limit dose (2,000 mg/kg/day).
No dermal toxicity was observed in rats up to the limit dose (1,000 mg/
kg/day). Picarbutrazox is categorized as having low acute lethality
through the oral, dermal, and inhalation routes. It is minimally
irritating to the eye and is neither a dermal irritant nor sensitizer.
In accordance with the EPA's Final Guidelines for Carcinogen Risk
Assessment (March 2005), the Agency classified picarbutrazox as
``Suggestive Evidence of Carcinogenic Potential'' based on an increase
in the incidence of thyroid follicular cell tumors, driven by adenomas
in male and female rats and combined thyroid follicular adenomas/
carcinomas in male rats. There is no concern for genotoxicity or
mutagenicity and no treatment-related tumors were observed in mice.
Based on its weight-of-evidence analysis, the Agency has determined
that quantification of risk using a non-linear approach (i.e., chronic
reference dose (cRfD)) will adequately account for all chronic
toxicity, including potential carcinogenicity, that could result from
exposure to picarbutrazox. The chronic reference dose is several times
lower than the dose at which tumors were observed.
Specific information on the studies received and the nature of the
adverse effects caused by picarbutrazox as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at http://www.regulations.gov in document ``Picarbutrazox. Human Health Risk
Assessment in Support of a New Active Ingredient for Use on Corn and
Soybean Seed and Turf'', dated December 18, 2020, hereinafter
``Picarbutrazox Human Health Risk Assessment'' in docket ID number EPA-
HQ-OPP-2017-0653.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticide.
A summary of the toxicological endpoints for picarbutrazox used for
human risk assessment can be found on pages 19-20 in the Picarbutrazox
Human Health Risk Assessment.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to picarbutrazox, EPA considered exposure under the
petitioned-for tolerances. EPA assessed dietary exposures from
picarbutrazox in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure. No such effects were
identified in the toxicological studies for picarbutrazox; therefore, a
quantitative acute dietary exposure assessment is unnecessary.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the United States
Department of Agriculture's (USDA's) National Health and Nutrition
Examination Survey, What We Eat in America, (NHANES/WWEIA). As to
residue levels in food, EPA conducted an unrefined chronic dietary
exposure assessment using tolerance-level residues, 100 percent crop
treated (PCT), and default processing factors.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that a nonlinear RfD approach is appropriate for assessing
cancer risk to picarbutrazox. Quantification of risk using a non-linear
approach (i.e., cRfD) will adequately account for all chronic toxicity,
including potential carcinogenicity, that could result from exposure to
picarbutrazox.
iv. Anticipated residue and percent crop treated (PCT) information.
EPA did not use anticipated residue and/or PCT information in the
dietary assessment for picarbutrazox. Tolerance level residues and/or
100 PCT were assumed for all food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for picarbutrazox in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of picarbutrazox. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
Using the Pesticides in Water Calculator (PWC) ver. 1.52, EPA
calculated the estimated drinking water concentrations (EDWCs) of
picarbutrazox for chronic exposures in surface and ground water. The
groundwater estimates were significantly lower. EPA used the modeled
EDWC of 2.56 ppb directly in dietary exposure model to account for the
contribution of picarbutrazox residues in drinking water for the
chronic dietary risk assessment.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Picarbutrazox is
currently proposed for turf uses that could result in residential
exposures. EPA assessed residential exposure using the following
assumptions: There is the potential for post-application exposure for
adults and children following turf treatments made by professional
applicators with picarbutrazox. A dermal exposure assessment was not
quantitatively conducted because a dermal POD was not selected. The
quantitative exposure/risk assessment for residential post-application
exposures is based only on incidental oral scenarios for children 1 to
<2 years old from hand to mouth activities on treated turf. Post-
application exposure and risk estimates indicate that the short-term
incidental oral MOEs, ranging from 970 to 360,000, are not of concern
(i.e., MOEs >=30). Further information regarding EPA standard
assumptions and generic
[[Page 12832]]
inputs for residential exposures may be found at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/standard-operating-procedures-residential-pesticide.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found picarbutrazox to share a common mechanism of
toxicity with any other substances, and picarbutrazox does not appear
to produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
picarbutrazox does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. There is no evidence of
increased prenatal susceptibility in rats or rabbits or postnatal
susceptibility in rats, with no adverse effects observed in the
developmental toxicity studies.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for picarbutrazox is complete.
ii. There is no indication that picarbutrazox is a neurotoxic
chemical and there is no need for a developmental neurotoxicity study
or additional UFs to account for neurotoxicity.
iii. There is no evidence that picarbutrazox results in increased
susceptibility in in utero rats or rabbits in the prenatal
developmental studies or in young rats in the 2-generation reproduction
study.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT, tolerance-level residues, default processing factors, and
modeled drinking water estimates. EPA made conservative (protective)
assumptions in the ground and surface water modeling used to assess
exposure to picarbutrazox in drinking water. EPA used similarly
conservative assumptions to assess post-application exposure of
children as well as incidental oral exposure of toddlers. These
assessments will not underestimate the exposure and risks posed by
picarbutrazox.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). Short-, intermediate-, and
chronic-term risks are evaluated by comparing the estimated aggregate
food, water, and residential exposure to the appropriate PODs to ensure
that an adequate MOE exists.
1. Acute risk. An acute aggregate risk assessment takes into
account acute exposure estimates from dietary consumption of food and
drinking water. No adverse effect resulting from a single oral exposure
was identified and no acute dietary endpoint was selected. Therefore,
picarbutrazox is not expected to pose an acute risk.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
picarbutrazox from food and water will utilize <1% of the cPAD for all
infants (<1 year old), the population group receiving the greatest
exposure. Based on the explanation in Unit III.C.3., regarding
residential use patterns, chronic residential exposure to residues of
picarbutrazox is not expected.
3. Short-term and Intermediate-term risk. Short-term and
intermediate-term aggregate exposure takes into account short-term or
intermediate-term residential exposure plus chronic exposure to food
and water (considered to be a background exposure level). Picarbutrazox
is currently proposed for uses that could result in short-term and
intermediate-term residential exposure, and the Agency has determined
that it is appropriate to aggregate chronic exposure through food and
water with short-term or intermediate-term residential exposures to
picarbutrazox.
Using the exposure assumptions described in this unit for short-
term and intermediate-term exposures, EPA has concluded the combined
short-term or intermediate-term food, water, and residential exposures
result in aggregate MOE of 950 for children 1 to <2 years old from
dietary (food and drinking water) and incidental oral exposure from
hand-to-mouth activities from post-application exposure to turf
applications. Because EPA's level of concern for picarbutrazox is an
MOE of 30 or below, these MOEs are not of concern.
4. Aggregate cancer risk for U.S. population. As stated in Unit
III.A., a separate cancer analysis was not conducted as the chronic
assessment adequately accounts for all chronic toxicity, including
potential carcinogenicity. Based on the lack of chronic risk, EPA
concludes that aggregate exposure to picarbutrazox will not pose a
cancer risk.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to picarbutrazox residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (liquid chromatography with tandem
mass spectroscopy (LC/MS/MS) and high-performance liquid chromatography
(HPLC/MS/MS)) is available to enforce the tolerance expression.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program,
[[Page 12833]]
and it is recognized as an international food safety standards-setting
organization in trade agreements to which the United States is a party.
EPA may establish a tolerance that is different from a Codex MRL;
however, FFDCA section 408(b)(4) requires that EPA explain the reasons
for departing from the Codex level.
Picarbutrazox is a new active ingredient, and no maximum residue
limits (MRLs) have yet been established by Codex.
C. Revisions to Petitioned-For Tolerances
The Agency is establishing tolerances for picarbutrazox using
tolerance expression and commodity definitions that conform to current
practices. Additionally, the Agency is establishing a tolerance on
corn, pop, stover and corn, field, stover; the petitioner requested a
tolerance on ``corn, stover'', but the correct terminology is ``corn,
pop, stover'' and ``corn, field, stover''.
V. Conclusion
Therefore, tolerances are established for residues of
picarbutrazox, 1,1-Dimethylethyl N-(6-((((Z)-((1-methyl-1H-tetrazol-5-
yl) phenylmethylene) amino)oxy)methyl)-2-pyridinyl)carbamate, in or on
corn, field, forage at 0.01 ppm; corn, field, grain at 0.01 ppm; corn,
field, stover at 0.01 ppm; corn, pop, grain at 0.01 ppm; corn, pop,
stover at 0.01 ppm; corn, sweet, forage at 0.01 ppm; corn, sweet,
kernel plus cob with husks removed at 0.01 ppm; corn, sweet, stover at
0.01 ppm; soybean, forage at 0.01 ppm; soybean, hay at 0.01 ppm and
soybean, seed at 0.01 ppm.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), nor is it considered a
regulatory action under Executive Order 13771, entitled ``Reducing
Regulations and Controlling Regulatory Costs'' (82 FR 9339, February 3,
2017). This action does not contain any information collections subject
to OMB approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501
et seq.), nor does it require any special considerations under
Executive Order 12898, entitled ``Federal Actions to Address
Environmental Justice in Minority Populations and Low-Income
Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerances in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or Tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
Tribal Governments, on the relationship between the National Government
and the States or Tribal Governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian Tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Edward Messina,
Acting Director, Office of Pesticide Programs.
Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Add Sec. 180.718 to subpart C to read as follows:
Sec. 180.718 Picarbutrazox; tolerances for residues.
(a) General. Tolerances are established for residues of the
fungicide picarbutrazox, including its metabolites and degradates, in
or on the commodities to Table 1 of this section. Compliance with the
tolerance levels specified in Table 1 is to be determined by measuring
only picarbutrazox (1,1-dimethylethyl N-[6-[[[(Z)-[(1-methyl-1H-
tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate
in or on the commodity.
Table 1 to Paragraph (a)
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Corn, field, forage......................................... 0.01
Corn, field, grain.......................................... 0.01
Corn, field, stover......................................... 0.01
Corn, pop, grain............................................ 0.01
Corn, pop, stover........................................... 0.01
Corn, sweet, forage......................................... 0.01
Corn, sweet, kernel plus cob with husks removed............. 0.01
Corn, sweet, stover......................................... 0.01
Soybean, forage............................................. 0.01
Soybean, hay................................................ 0.01
Soybean, seed............................................... 0.01
------------------------------------------------------------------------
(b)-(d) [Reserved]
[FR Doc. 2021-04251 Filed 3-4-21; 8:45 am]
BILLING CODE 6560-50-P